Unknown

Dataset Information

0

Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection.


ABSTRACT: Tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) are used for HIV treatment and prevention. Previously, we found that topical rectal tenofovir gel caused immunological changes in the mucosa. Here, we assess the effect of oral TDF/FTC in three HIV pre-exposure prophylaxis trials, two with gastrointestinal and one with cervicovaginal biopsies. TDF/FTC induces type I/III interferon-related (IFN I/III) genes in the gastrointestinal tract, but not blood, with strong correlations between the two independent rectal biopsy groups (Spearman r = 0.91) and between the rectum and duodenum (r = 0.81). Gene set testing also indicates stimulation of the type I/III pathways in the ectocervix and of cellular proliferation in the duodenum. mRNA sequencing, digital droplet PCR, proteomics, and immunofluorescence confirm IFN I/III pathway stimulation in the gastrointestinal tract. Thus, oral TDF/FTC stimulates an IFN I/III signature throughout the gut, which could increase antiviral efficacy but also cause chronic immune activation in HIV prevention and treatment settings.

SUBMITTER: Hughes SM 

PROVIDER: S-EPMC7511692 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection.

Hughes Sean M SM   Levy Claire N CN   Calienes Fernanda L FL   Stekler Joanne D JD   Pandey Urvashi U   Vojtech Lucia L   Berard Alicia R AR   Birse Kenzie K   Noël-Romas Laura L   Richardson Brian B   Golden Jackelyn B JB   Cartwright Michael M   Collier Ann C AC   Stevens Claire E CE   Curlin Marcel E ME   Holtz Timothy H TH   Mugo Nelly N   Irungu Elizabeth E   Katabira Elly E   Muwonge Timothy T   Lama Javier R JR   Baeten Jared M JM   Burgener Adam A   Lingappa Jairam R JR   McElrath M Juliana MJ   Mackelprang Romel R   McGowan Ian I   Cranston Ross D RD   Cameron Mark J MJ   Hladik Florian F  

Cell reports. Medicine 20200922 6


Tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) are used for HIV treatment and prevention. Previously, we found that topical rectal tenofovir gel caused immunological changes in the mucosa. Here, we assess the effect of oral TDF/FTC in three HIV pre-exposure prophylaxis trials, two with gastrointestinal and one with cervicovaginal biopsies. TDF/FTC induces type I/III interferon-related (IFN I/III) genes in the gastrointestinal tract, but not blood, with strong correlations between th  ...[more]

Similar Datasets

| S-EPMC6969170 | biostudies-literature
| S-EPMC3093448 | biostudies-literature
| S-EPMC3534595 | biostudies-literature
| S-EPMC6494375 | biostudies-literature
| S-EPMC6481751 | biostudies-literature
| S-EPMC8617889 | biostudies-literature
| S-EPMC5908836 | biostudies-literature
| S-EPMC9261327 | biostudies-literature
| S-EPMC7474884 | biostudies-literature
| S-EPMC7697763 | biostudies-literature